Tango Therapeutics Inc (TNGX)
6.98
+0.08
(+1.16%)
USD |
NASDAQ |
Oct 04, 16:00
6.98
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Shareholders Equity (Annual): 253.11M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 253.11M |
| December 31, 2022 | 249.48M |
| Date | Value |
|---|---|
| December 31, 2021 | 344.75M |
| December 31, 2020 | 38.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
38.60M
Minimum
2020
344.75M
Maximum
2021
221.48M
Average
251.29M
Median
Shareholders Equity (Annual) Benchmarks
| IDEAYA Biosciences Inc | 621.09M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 39.70M |